Paroxysmal Nocturnal Hemoglobinuria Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
APLS | D | Apellis Pharmaceuticals, Inc. | 0.00 | |
AKTX | B | Akari Therapeutics Plc | 0.00 | |
OMER | B | Omeros Corporation | 0.00 |
Related Industries: Biotechnology
Related Stock Lists:
Biopharmaceutical
Hemoglobinuria
Medicine
Acquired Hemolytic Anemia
Autoimmune And Inflammatory Disease
Complement System
Hemoglobin
Hemolytic Uremic Syndrome
Inflammatory Diseases
Macular Degeneration
Organ Systems
Addiction
Arthroscopy
Autoimmunity
C5a
Cataracts
Chronic Obstructive Pulmonary Disease
Clinical Medicine
Clinical Research
Clinical Trial
Related ETFs - A few ETFs which own one or more of the above listed Paroxysmal Nocturnal Hemoglobinuria stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
BBP | B | BioShares Biotechnology Products Fund | 1.57 | |
LABD | F | Direxion Daily S&P Biotech Bear 3X Shares | 1.24 | |
BTEC | B | Principal Healthcare Innovators Index ETF | 1.16 | |
JFWD | C | Jacob Funds Inc. Jacob Forward ETF | 0.85 | |
XBI | B | SPDR S&P Biotech ETF | 0.73 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 11 | APLS | Apellis (APLS) Up on Upbeat GA Data From Long-Term Syfovre Study |
Related Industries:
Biotechnology
Related Stock Lists:
Biopharmaceutical
Hemoglobinuria
Medicine
Acquired Hemolytic Anemia
Autoimmune And Inflammatory Disease
Complement System
Hemoglobin
Hemolytic Uremic Syndrome
Inflammatory Diseases
Macular Degeneration
Organ Systems
Addiction
Arthroscopy
Autoimmunity
C5a
Cataracts
Chronic Obstructive Pulmonary Disease
Clinical Medicine
Clinical Research
Clinical Trial
- Paroxysmal Nocturnal Hemoglobinuria
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired, life-threatening blood disorder characterized by the destruction of red blood cells (hemolysis). It is caused by a genetic mutation that results in the absence of certain proteins on the surface of red blood cells. This leads to the destruction of red blood cells by the body's own immune system. Symptoms of PNH include anemia, fatigue, abdominal pain, and blood clots. Treatment typically involves medications to reduce the destruction of red blood cells and to prevent blood clots.
Popular Now
Recent Comments
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- ZealousTrout235 on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
- TraderMike on Market Recap for Tuesday, May 21, 2024
- CharmingMole371 on Market Recap for Tuesday, May 21, 2024
- TraderMike on IZM
From the Blog
Featured Articles